ATLASAmneal Pharmaceuticals (AMRX) earnings date: Nov 3, 2026
Amneal Pharmaceuticals (AMRX) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, before the open. Analysts expect EPS of $0.23.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AMRX
| Last price | $21.51 (+0.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.2% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Amneal Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Amneal Pharmaceuticals reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Amneal Pharmaceuticals. You can switch it off at any time.
Alert me before AMRX reportsFree to start. Creating an account takes under a minute.
AMRX earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.23 |
| Last report | Jul 30, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | -4.5% |
| Average move around a report | ±3.7% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
Amneal Pharmaceuticals earnings history: last 5 reports
Amneal Pharmaceuticals last reported on Jul 30, 2026: EPS of $0.30 against an estimate of $0.23 (+30.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 30, 2026 | $0.23 | $0.30 | +30.4% | Beat | -4.1% |
| May 7, 2026 | $0.17 | $0.27 | +58.8% | Beat | -3.1% |
| Mar 24, 2026 | -$0.40 | -$1.00 | -150.0% | Miss | +2.9% |
| Feb 27, 2026 | $0.18 | $0.21 | +16.7% | Beat | -5.0% |
| Oct 30, 2025 | $0.14 | $0.17 | +21.4% | Beat | +3.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AMRX
See the fair value, the probability range and the earnings history of Amneal Pharmaceuticals on its ATLAS page.
Amneal Pharmaceuticals (AMRX) stock analysisPlans from €3.99 a month.
Amneal Pharmaceuticals earnings: frequently asked questions
When does Amneal Pharmaceuticals (AMRX) report earnings?
Amneal Pharmaceuticals is scheduled to report on Tuesday, November 3, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AMRX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.23 per share (USD). Estimates can change before the report.
How often does AMRX beat earnings estimates?
Of its last 5 reports with a recorded result, Amneal Pharmaceuticals beat the EPS estimate 4 times; the average surprise was -4.5%. Past results do not predict the next one.
How much does AMRX move around earnings?
Over its last 5 reports the stock moved an average of 3.7% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Amneal Pharmaceuticals beat earnings estimates last quarter?
Amneal Pharmaceuticals last reported on Jul 30, 2026: EPS of $0.30 against an estimate of $0.23 (+30.4% surprise), a beat.
How much does AMRX usually move in a day?
On a normal trading day the ATLAS model puts AMRX’s one-day range at about ±2.2%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer